Heart attacks more likely in those with low blood phosphate levels: study

19bb24d0-1c58-4745-80fd-6c0c90ee75c8articleimage.jpg

13 Nov 2017 --- Insufficient levels of phosphate in the blood may pose a particular danger to cardiovascular health, according to new research from the University of Surrey. The study’s findings contradict previous research in this area, which suggested low volumes of the mineral was beneficial to the heart.

Phosphate is an important mineral in the body and helps to regulate blood biochemistry, which can impact on the working of the heart. It plays a crucial role in enabling red blood cells to deliver oxygen to the body's tissues and can be found in protein-rich foods such as meat, poultry and fish.

The study, using data from the RCGP Research and Surveillance Centre, examined phosphate levels of more than 100,000 patients, over five and nine-year intervals, and the impact on their cardiac health. 

The researchers found that those with low levels (below 0.75 mmol/L) of the mineral in their blood were at a similar risk of developing coronary problems as those with elevated levels (above 1.5 mmol/L). Instances of both conditions were high amongst those with low and excessive levels of phosphate in the blood. However, cardiac events in those with mid-range (1-1.25 mmol/L) levels were significantly less.

Risks associated with high levels of phosphate in the blood have previously been proven by the scientific community, but this is the first time the dangers of low levels have been identified as potentially being just as dangerous.

“The importance of phosphate in primary and secondary healthcare should be reviewed. It is often overlooked in blood tests yet phosphate may be a new risk factor for heart disease in adults,” says lead author Dr. Nick Hayward, who conducted the research while at the University of Surrey.

“In light of our findings, we would suggest that clinicians consider people with low phosphate levels to be at higher cardiovascular risk and assess ways in which this can be reduced for each patient,” says Dr. Andy McGovern, also from the University of Surrey.

RELATED ARTICLES
Homepicture

Probiotics: Scientists investigate how seaweed can give a dietary boost to gut bacteria

11 May 2018 US researchers examining how to manipulate gut ...

Homepicture

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 Novartis has entered into an agreement and plan ...

Homepicture

Probi signs agreement with pharma company Cilag on probiotic OTC product

23 Mar 2018 Probi has signed a long-term agreement with ...

Homepicture

Gelita develops controlled soft gelatin capsule fill release

12 Mar 2018 Gelita is offering manufacturers of soft gelatin ...